Article
KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples
1 Oct 2020
Abstract excerpt
Background: Kirsten rat sarcoma vial oncogene (KRAS) is one of the most prevalent oncogenes in multiple cancer types, but the incidence is different between the Asian and non-Asian populations. The recent development of KRAS G12C targeting drug has shown great promise. It is thus important to understand the genomic landscape of KRAS G12C in a specific population. Methods: Sequencing data of 11,951 tumor samples...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
